From: Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV
Characteristic | N = 20 (%) |
---|---|
Sex | |
Male | 19 (95%) |
Female | 1 (5%) |
Median age, years (IQR) | 48.1 (40.5, 57.0) |
Nadir CD4 + T cell count (IQR, cells/μL) | 22.0 (11.0, 109.0) |
Nadir CD4/CD8 T-cell ratio (IQR, cells/μL) | 0.06 (0.04, 0.18) |
Viral load, > 2 years (copies/mL) | < 50 (100%) |
ART duration, years (IQR) | 5.0 (3.0, 7.3) |
Baseline CD4 + T cell count (IQR, cells/μL) | 215.3 (190.1, 269.2) |
Baseline CD4/CD8 T-cell ratio (IQR, cells/μL) | 0.35 (0.24, 0.43) |
ART regimens | |
NRTIs + NNRTI | 14 (70%) |
NRTIs | 3 (15%) |
NRTIs + PI | 2 (10%) |
NRTI + INSTI | 1 (5%) |
Past history | |
Hyperlipidemia | 6 (30%) |
Syphilis | 3 (15%) |
Hypercholesterolemia | 2 (10%) |
Hypertension | 2 (10%) |
Uarthritis | 2 (10%) |
Diabetes | 1 (5%) |
Renal insufficiency | 1 (5%) |
Hepatitis C infection | 0 (0%) |